Budoprutug

Drug identity checked against registry records

Also recorded as TNT119

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)NCT07564596CLYMPhase 1, Phase 2Recruiting2027-09Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.